Background -Significant morbidity and mortality result from the ineffective evacuation of empyema.
Abstract
Background -Significant morbidity and mortality result from the ineffective evacuation of empyema. Failure of conventional first line treatment with closed intercostal tube drainage and antibiotic therapy may result in fibrin deposition and loculated empyema. Enzymatic debridement using intrapleural instillation of streptokinase is a non-invasive therapeutic option which may obviate the need for surgical intervention. Methods -Eleven adults with multiloculated post-pneumonic empyemas who had failed to respond satisfactorily to intercostal tube drainage and antibiotic therapy were treated with intrapleural streptokinase between November 1992 and January 1994. A small catheter was inserted under ultrasound guidance into a loculation within the pleural space. Aliquots of 250 000 units of streptokinase in 100 ml normal saline were instilled into the pleural cavity and the tube clamped for four hours. Response was assessed by clinical outcome, measurement of drain output after unclamping, and subsequent pleural ultrasound, chest radiography, or both. Results -Streptokinase enhanced drainage in all patients. Complete resolution of the empyema with re-expansion of the underlying lung was effected in eight patients, all of whom remain well. Further resolution of minimal pleural thickening was shown on subsequent chest radio- . i with myocarditis who was on the waiting list for cardiac transplantation had a pyopneumothorax. Following streptokinase instillation, the empyema drained but the pneumothorax persisted. He therefore underwent surgery for non-resolution ofthe pneumothorax but died perioperatively from cardiac failure.
The number of streptokinase instillations per patient ranged from two to six with a median Figure 3 Chest radiographs ofpatient 11 (A) at presentation, (B) with catheter in situ before streptokinase administration, and (C) 11 weeks after treatment with streptokinase.
of three. The volume of empyema fluid drained per patient following streptokinase (after subtraction of the injected volumes) ranged from 100 ml to 4870 ml with a median of 900 ml (table). Streptokinase was well tolerated by all patients. One patient, a 74 year old woman, complained of mild ipsilateral chest pain after both instillations of streptokinase. There was no evidence of intrapleural haemorrhage or clinical manifestation ofsystemic coagulopathy.
Discussion
We have given intrapleural streptokinase to 11 patients with empyemas which have not resolved with intercostal tube drainage and antibiotic therapy. The next therapeutic manoevre would usually have been surgery. In our experience streptokinase promoted drainage of loculated empyemas, permitting clinical resolution and obviating thoracic surgery. In view of the considerable morbidity and mortality associated with decortication,9 the application of this non-invasive therapeutic option appears to be beneficial. Streptokinase effected complete resolution of the empyema in two patients (nos 7 and 11) who were at high risk of serious morbidity and mortality if they had undergone thoracotomy and decortication. In two patients, failure of streptokinase to achieve complete clinical resolution may be attributed to considerable pleural thickening which had developed before streptokinase therapy. It seems likely that, if enzymatic therapy is initiated early in the evolution of an empyema -tha; is, before fibrinopurulence is established and organisation occurs -more extensive surgical procedures could be avoided.
All patients tolerated intrapleural streptokinase well; only one complained of mild chest discomfort shortly after each streptokinase instillation. Other authors'0 have described the successful use of lignocaine given intrapleurally 15 minutes before streptokinase administration. It is of note that previous reports of anaphylaxis and febrile reactions developed in patients in whom streptokinase had been left in the pleural cavity for longer time periods (up to 24 hours).6"' It is likely that the shorter instillation time of four hours, combined with the use of only highly purified preparations, contributed to the lack of adverse reactions in this series. As in more recent studies,71' intrapleural haemorrhage did not occur. It is of note that steroid cover was not given in anticipation of possible systemic reactions to repeated streptokinase instillations which were given at intervals during a period of 20 and 35 days to two patients (nos 7 and 8 respectively); all such instillations were well tolerated. Radiological intervention with placement of small catheters under ultrasound or fluoroscopic control into specific loculations has optimised the outcome of this technique. Subsequent assessment with serial pleural ultrasound examinations has provided information on the presence or absence of fluid or pleural thickening. Indeed, the success of this technique may be attributed partly to the use of ultrasound guided drainage of large loculations, although it is noteworthy that, in this study, adequate drainage was not achieved by ultrasound guided placement of drains alone.
In summary, intrapleural purified streptokinase may .be used as an adjunct to initial chest tube drainage when there is a residual collection of pleural fluid. Streptokinase enhances the drainage of fluid which is loculated or is too viscous to be drained by tube thoracostomy alone. Subsequent surgical intervention is not jeopardised by the prior use of streptokinase. The optimum time for the introduction of intrapleural streptokinase in the medical management of complicated empyema remains controversial. Multicentre controlled trials will be necessary to clarify the role of this technique and such a trial is underway.
